Literature DB >> 1377456

Enzymatically amplified time-resolved fluorescence immunoassay with terbium chelates.

T K Christopoulos1, E P Diamandis.   

Abstract

We report an ultrasensitive, enzymatically amplified, time-resolved fluorescence immunoassay with a terbium chelate as the detectable moiety. In this immunoassay, the primary label is the enzyme alkaline phosphatase (ALP). ALP cleaves phosphate out of a fluorogenic substrate, 5-fluorosalicyl phosphate, to produce 5-fluorosalicylic acid (FSA). 5-Fluorosalicylic acid can then form a highly fluorescent ternary complex of the form FSA-Tb(3+)-EDTA, which can be quantified by measuring the Tb3+ fluorescence in a time-resolved mode. In this assay, exceptional sensitivity is achieved because of the enzymatic amplification introduced by ALP and the quantification by laser-induced microsecond time-resolved fluorometry. Time-resolved fluorometry is applicable because of the long fluorescence lifetime of the Tb3+ complexes. It is shown that in a model AFP assay 10(6) or 1.5 x 10(5) molecules can be detected (final assay volume, 100 microL) by using monoclonal or polyclonal detection antibodies, respectively. The assay demonstrates excellent precision (approximately 4%), and it seems to be highly suited for automated, sensitive, and rapid immunoassays.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1377456     DOI: 10.1021/ac00028a004

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  14 in total

1.  Characterization of the seminal plasma proteome in men with prostatitis by mass spectrometry.

Authors:  Daniel Kagedan; Irene Lecker; Ihor Batruch; Christopher Smith; Ilia Kaploun; Kirk Lo; Ethan Grober; Eleftherios P Diamandis; Keith A Jarvi
Journal:  Clin Proteomics       Date:  2012-02-06       Impact factor: 3.988

2.  Novel sensitive high-throughput screening strategy for nitrilase-producing strains.

Authors:  Qing Zhu; Ao Fan; Yuanshan Wang; Xiaoqin Zhu; Zhao Wang; Minghuo Wu; Yuguo Zheng
Journal:  Appl Environ Microbiol       Date:  2007-08-03       Impact factor: 4.792

3.  Immunocapture-Selected Reaction Monitoring Screening Facilitates the Development of ELISA for the Measurement of Native TEX101 in Biological Fluids.

Authors:  Dimitrios Korbakis; Davor Brinc; Christina Schiza; Antoninus Soosaipillai; Keith Jarvi; Andrei P Drabovich; Eleftherios P Diamandis
Journal:  Mol Cell Proteomics       Date:  2015-03-26       Impact factor: 5.911

4.  Development and evaluation of a competitive time-resolved immunofluorometric assay for the estrogen-regulated protein pS2.

Authors:  R S Rosenberg Zand; D J Jenkins; E P Diamandis
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

5.  Quantitative analysis of mutant p53 protein in breast tumor cytosols and study of its association with other biochemical prognostic indicators in breast cancer.

Authors:  M A Levesque; E P Diamandis; H Yu; D J Sutherland
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

Review 6.  Lanthanide-based time-resolved luminescence immunoassays.

Authors:  A K Hagan; T Zuchner
Journal:  Anal Bioanal Chem       Date:  2011-05-11       Impact factor: 4.142

7.  Transcriptional upregulation of human tissue kallikrein 6 in ovarian cancer: clinical and mechanistic aspects.

Authors:  S J C Shan; A Scorilas; D Katsaros; E P Diamandis
Journal:  Br J Cancer       Date:  2007-01-29       Impact factor: 7.640

8.  OVSCORE - a validated score to identify ovarian cancer patients not suitable for primary surgery.

Authors:  Julia Dorn; Holger Bronger; Ronald Kates; Julia Slotta-Huspenina; Barbara Schmalfeldt; Marion Kiechle; Eleftherios P Diamandis; Antoninus Soosaipillai; Manfred Schmitt; Nadia Harbeck
Journal:  Oncol Lett       Date:  2014-10-24       Impact factor: 2.967

9.  Immunofluorometric analysis of p53 protein and prostate-specific antigen in breast tumours and their association with other prognostic indicators.

Authors:  M A Levesque; G M Clark; H Yu; E P Diamandis
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

10.  Identification of heat shock protein 90 and other proteins as tumour antigens by serological screening of an ovarian carcinoma expression library.

Authors:  L-Y Luo; I Herrera; A Soosaipillai; E P Diamandis
Journal:  Br J Cancer       Date:  2002-07-29       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.